These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 20127126)

  • 1. Endothelial dysfunction: a strategic target in the treatment of hypertension?
    Tang EH; Vanhoutte PM
    Pflugers Arch; 2010 May; 459(6):995-1004. PubMed ID: 20127126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human endothelial dysfunction: EDCFs.
    Virdis A; Ghiadoni L; Taddei S
    Pflugers Arch; 2010 May; 459(6):1015-23. PubMed ID: 20107832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelium-dependent contractions and endothelial dysfunction in human hypertension.
    Versari D; Daghini E; Virdis A; Ghiadoni L; Taddei S
    Br J Pharmacol; 2009 Jun; 157(4):527-36. PubMed ID: 19630832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetes.
    Matsumoto T; Goulopoulou S; Taguchi K; Tostes RC; Kobayashi T
    Br J Pharmacol; 2015 Aug; 172(16):3980-4001. PubMed ID: 26031319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial dysfunction in hypertension.
    Puddu P; Puddu GM; Zaca F; Muscari A
    Acta Cardiol; 2000 Aug; 55(4):221-32. PubMed ID: 11041120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary endothelial dysfunction: hypertension and heart failure.
    Boulanger CM
    J Mol Cell Cardiol; 1999 Jan; 31(1):39-49. PubMed ID: 10072714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenic Mechanisms of Pulmonary Arterial Hypertension: Homeostasis Imbalance of Endothelium-Derived Relaxing and Contracting Factors.
    Zhu J; Yang L; Jia Y; Balistrieri A; Fraidenburg DR; Wang J; Tang H; Yuan JX
    JACC Asia; 2022 Dec; 2(7):787-802. PubMed ID: 36713766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular effects of endothelin-1 in essential hypertension: relationship with cyclooxygenase-derived endothelium-dependent contracting factors and nitric oxide.
    Taddei S; Virdis A; Ghiadoni L; Salvetti A
    J Cardiovasc Pharmacol; 2000; 35(4 Suppl 2):S37-40. PubMed ID: 10976779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Participation of endothelium-derived vasoconstrictor factors in arterial hypertension].
    Lahera V; Navarro-Cid J; Maeso R; Cachofeiro V
    Rev Esp Cardiol; 1999; 52 Suppl 3():4-11. PubMed ID: 10614144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial dysfunction in spontaneously hypertensive rats: consequences of chronic treatment with losartan or captopril.
    Rodrigo E; Maeso R; Muñoz-García R; Navarro-Cid J; Ruilope LM; Cachofeiro V; Lahera V
    J Hypertens; 1997 Jun; 15(6):613-8. PubMed ID: 9218180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COX-mediated endothelium-dependent contractions: from the past to recent discoveries.
    Wong MS; Vanhoutte PM
    Acta Pharmacol Sin; 2010 Sep; 31(9):1095-102. PubMed ID: 20711228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase-2-derived prostaglandin F2alpha mediates endothelium-dependent contractions in the aortae of hamsters with increased impact during aging.
    Wong SL; Leung FP; Lau CW; Au CL; Yung LM; Yao X; Chen ZY; Vanhoutte PM; Gollasch M; Huang Y
    Circ Res; 2009 Jan; 104(2):228-35. PubMed ID: 19096033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelium-derived relaxing and contracting factors.
    Rubanyi GM
    J Cell Biochem; 1991 May; 46(1):27-36. PubMed ID: 1874796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial dysfunction in hypertension.
    Vanhoutte PM
    J Hypertens Suppl; 1996 Dec; 14(5):S83-93. PubMed ID: 9120689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different effects of antihypertensive drugs on endothelial dysfunction.
    Puddu P; Puddu GM; Cravero E; Muscari A
    Acta Cardiol; 2004 Oct; 59(5):555-64. PubMed ID: 15529563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium channel blockers, endothelial dysfunction, and combination therapy.
    Schulman IH; Zachariah M; Raij L
    Aging Clin Exp Res; 2005 Aug; 17(4 Suppl):40-5. PubMed ID: 16640172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rationale for treatment of endothelial dysfunction in hypertension.
    Ruschitzka F; Corti R; Noll G; Lüscher TF
    J Hypertens Suppl; 1999 Feb; 17(1):S25-35. PubMed ID: 10340841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive drugs and reversing of endothelial dysfunction in hypertension.
    Taddei S; Virdis A; Ghiadoni L; Sudano I; Salvetti A
    Curr Hypertens Rep; 2000 Feb; 2(1):64-70. PubMed ID: 10981130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of endothelial dysfunction as a surrogate endpoint in the treatment of hypertension.
    Santoso T
    Curr Hypertens Rep; 2000 Jun; 2(3):227-9. PubMed ID: 10981153
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hypertension and endothelial dysfunction].
    Zoghi M; Nalbantgil I
    Anadolu Kardiyol Derg; 2002 Jun; 2(2):142-7, AXVIII. PubMed ID: 12134540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.